Literature DB >> 11945023

Ischemia-induced association of the stress protein alpha B-crystallin with I-band portion of cardiac titin.

Nikola Golenhofen1, Anja Arbeiter, Rainer Koob, Detlev Drenckhahn.   

Abstract

During ischemia the cardiac stress protein, alpha B-crystallin, was shown by immunoelectron microscopy to translocate to the N(2)-line area of myofibrillar I-bands of rat cardiomyocytes where alpha B-crystallin resisted extraction with 1 m NaSCN and 2 m urea as did titin. Actin became completely extracted under these conditions, indicating association of alpha B-crystallin with titin the only remaining non-actin cytoskeletal component of I-bands outside Z-disks. Titin, extracted from ischemic pig myocardium, was shown to copurify with alpha B-crystallin. Further evidence for binding of alpha B-crystallin to titin was obtained by dot-blot assays in which biotinylated alpha B-crystallin was demonstrated to bind to the titin-enriched fraction immobilized on nitrocellulose. Binding of alpha B-crystallin to titin during cardiac ischemia could serve to stabilize titin against denaturation and might provide an endogenous mechanism to delay ischemic damage of this important elastic component of myofibrils. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945023     DOI: 10.1006/jmcc.2001.1513

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  37 in total

1.  Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle.

Authors:  Nikola Golenhofen; Ming Der Perng; Roy A Quinlan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2004-10-12       Impact factor: 4.304

2.  Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone alphaB-crystallin with disease-causing mutations.

Authors:  Yi Zhu; Julius Bogomolovas; Siegfried Labeit; Henk Granzier
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

Review 3.  Build it up-Tear it down: protein quality control in the cardiac sarcomere.

Authors:  Monte S Willis; Jonathan C Schisler; Andrea L Portbury; Cam Patterson
Journal:  Cardiovasc Res       Date:  2008-10-29       Impact factor: 10.787

Review 4.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 5.  The BAG3-dependent and -independent roles of cardiac small heat shock proteins.

Authors:  Xi Fang; Julius Bogomolovas; Christa Trexler; Ju Chen
Journal:  JCI Insight       Date:  2019-02-21

6.  Chaperones: needed for both the good times and the bad times.

Authors:  Roy A Quinlan; R John Ellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-03-25       Impact factor: 6.237

7.  Phenotype of cardiomyopathy in cardiac-specific heat shock protein B8 K141N transgenic mouse.

Authors:  Atsushi Sanbe; Tetsuro Marunouchi; Tsutomu Abe; Yu Tezuka; Mizuki Okada; Sayuri Aoki; Hideki Tsumura; Junji Yamauchi; Kouichi Tanonaka; Hideo Nishigori; Akito Tanoue
Journal:  J Biol Chem       Date:  2013-02-06       Impact factor: 5.157

8.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

Review 9.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

10.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.